Babiuk, L. A. and Tikoo, S. K. (2000) Adenoviruses as vectors for delivering vaccines to mucosal surfaces J Biotechnol, 83, 105-113. Full article

Bachmaier, K., Neu, N., Maza, L. M. d. l., Pal, S., Hessel, A. and Penninger, J. M. (1999). Chlamydia infections and heart disease linked through antigenic mimicry. Science, 283, 1335-1339. Full article

Bailey, R., Duong, T., Carpenter, R., Whittle, H. and Mabey, D. (1999). The duration of human ocular Chlamydia trachomatis infection is age dependent.  Epidemiol Infect, 123, 479-486.

Bailey, R. L., Kajbaf, M., Whittle, H. C., Ward, M. E. and Mabey, D. C. (1993). The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol Infect, 111, 315-324.

Bain, D. L., Lietman, T., Rasmussen, S., Kalman, S., Fan, J., Lammel, C., Zhang, J. Z., Dawson, C. R., Schachter, J. and Stephens, R. S. (2001). Chlamydial genovar distribution after community wide antibiotic treatment. J. Infect Dis, 184, 1581-1588. Full article

Beatty, P. R. and Stephens, R. S. (1994). CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J.Immunol., 153, 4588-4595.

Belay, T., Eko, F. O., Ananaba, G. A., Bowers, S., Moore, T., Lyn, D. and Igietseme, J. U. (2002). Chemokine and chemokine receptor dynamics during genital chlamydial infection.  Infect Immun, 70, 844-850. Full article

Bennink, J. R. and Yewdell, J. W. (1990). Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function.  Curr Top Microbiol Immunol, 163, 153-184.

Black, C. M. and Morse, S. A. (2000). The Use of Molecular Techniques for the Diagnosis and Epidemiologic Study of Sexually Transmitted Infections. Curr. Infect. Dis. Rep, 2, 31-43.

Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A. and Sinigaglia, F. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.  J. Exp. Med, 187, 129-134. Full article

Brunham, R. C. and Zhang, D. J. (1999). Transgene as vaccine for chlamydia. Am Heart J, 138, S519-S522.

Brunham, R. C., Zhang, D. J., Yang, X. and McClarty, G. M. (2000). The potential for vaccine development against chlamydial infection and disease. J Infect Dis, 181, S538-S543.

Buzoni-Gatel, D., Guilloteau, L., Bernard, F., Bernard, S., Chardes, T. and Rocca, A. (1992). Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells.  Immunol., 77, 284-288.

Byrd, T. F. and Horwitz, M. A. (1993). Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J.Clin.Invest., 91, 969-976.

Byrne, G. I. (1998) In Chlamydial Infections(Eds, Stephens, R. S., Byrne, G. I., Christainsen, G., Clarke, I. N., Grayston, J. T., Rank, R. G., Ridgway, G. L., Saikku, P., Schachter, J. and Stamm, W. E.), pp. 365-374.

Byrne, G. I., Lehmann, L. K. and Landry, G. J. (1986). Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect.Immun., 53, 347-351.

Chen, B., Stout, R. and Campbell, W. F. (1996). Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells.  FEMS Immunol. Med. Microbiol., 14, 109-120.

Chesson, H. W. and Pinkerton, S. D. (2000). Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions.  J. Acquir immune Defic. Syndr, 24, 48-56.

Cohen, C. R. and Brunham, R. C. (1999). Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Transm Infect, 75, 21-24.

Cohen, C. R., Nguti, R., Bukusi, E. A., Lu, H., Shen, C., Luo, M., Sinei, S., Plummer, F., Bwayo, J. and Brunham, R. C. (2000). Human immunodeficiency virus type 1-infected women exhibit reduced interferon-gamma secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes.  J Infect Dis, 182, 1672-1677.

Cohen, C. R., Plummer, F. A., Mugo, N., Maclean, I., Shen, C., Bukusi, E. A., Irungu, E., Sinei, S., Bwayo, J. and Brunham, R. C. (1999). Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission?
 AIDS, 25, 327-332.

Cotter, T. W., Ramsey, K. H., Miranpuri, G. S., Poulsen, C. E. and Byrne, G. I. (1997). Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun, 65, 2145-2152. Full article

Darville, T., Andrews, J., C.W, Sikes, J. D., Fraley, P. L., Braswell, L. and Rank, R. G. (2001a). Mouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response. Infect Immun, 69, 7419-7424. Full article

Darville, T., Andrews, J., C.W, Sikes, J. D., Fraley, P. L. and Rank, R. G. (2001b). Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection. Infect Immun, 69, 3556-3561. Full article

Dawson, C. R. and Schachter, J. (2002). Should trachoma be treated with antibiotics? Lancet, 359, 184-185. [Commentary] Full article

de la Maza, L. M. and Peterson, E. M. (2002). Vaccines for Chlamydia trachomatis infections. Curr Opin Investig Drugs, 3, 980-986.

de la Maza, M. A. and de la Maza, L. M. (1995). A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine, 13, 119-127.

de Battista, J., Timms, P., Allan, J. and Allan, J. (2002). Reduced levels of gamma-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections. Immunol Lett, 81, 205-210.

Diamant, J., Benis, R., Schachter, J., Moncada, J., Pang, F., Jha, H. C., Bhatta, R. C., Porco, T. and Lietman, T. (2001). Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic Epidemiol, 8, 109-117.

Dong-Ji, Z., Yang, X., Shen, C., Lu, H., Murdin, A. and Brunham, R. C. (2000). Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect. Immun, 68, 3074-3078. Full article

Eko, F. O., Lubitz, W. and Igietseme, J. U. (2001) In 101st Gen Meeting of ASM, Vol. Ab. E-58 Orlando FL, pp. 341.

Eko, F. O., Witte, A., Huter, V., Kuen, B., Furst-Ladani, S., Haslberger, A., Katinger, A., Hensel, A., Szostak, M. P., Resch, S., Mader, H., Raza, P., Brand, E., Marchart, J., Jechlinger, W., Haidinger, W. and Lubitz, W. (1999). New strategies for combination vaccines based on the extended recombinant bacterial ghost system. Vaccine, 17, 1643-1649.

Fan, T., Lu, H., Hu, H., Shi, L., McClarty, G. A., Nance, D. M., Greenberg, A. H. and Zhong, G. (1998). Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J.Exp.Med, 187, 487-496. Full article

Freidank, H. M., Billing, H. and Wiedmann-Al-Ahmad, M. (2001). Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis. J Med Microbiol, 50, 223-227.

Gallichan, W. S. & Rosenthal, K. L. (1995). Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine, 13, 1589-1595. Full article

Gentschev, I., Dietrich, G., Spreng, S., Kolb-Maurer, A., Daniels, J., HessmH, Kaufman, S. H. and Goebel, W. (2000). Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes. J Biotechnol, 83, 19-26. Full article

Gosselin, E. J., Wardwell, K., Gosselin, D. R., Alter, N., Fisher, J. L. and Guyre, P. M. (1992). Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens. J. Immunol, 149, 3477-3481.

Grayston, J. T., Wang, S.-P., Yeh, L. J. and Kuo C, C. (1985). Importance of reinfection in the pathogenesis of trachoma. Rev.Infect.Dis., 7, 717-725.

Gurunathan, S., Irvine, K. R., Wu, C. Y., Cohen, J. I., Thomas, E., Prussin, C., Restifo, N. P. and Seder, R. A. (1998). CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol, 161, 4563-4571. Full article

Gurunathan, S., Klinman, D. M. and Seder, R. A. (2000). DNA vaccines: immunology, application, and optimization. Annu Rev Immunol, 18, 927-974.

Hawkins, R. A., Rank, R. G. and Kelly, K. A. (2002). A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.  Infect Immun, 70, 5132-5139.

Heijnen, I. A., van Vugt, M. J., Fanger, N. A., Graziano, R. F., de Wit, T. P. M., Hofhuis, F. M. A., Guyre, P. M., Capel, P. J. A., Verbeek, J. S. and van de Winkel, J. G. J. (1996). Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest., 97, 331-338. Full article

Hewson, R. (2000). RNA viruses: emerging vectors for vaccination and gene therapy. Mol Med Today, 6, 28-35. Full article

Holm, S. O., Jha, H. C., Bhatta, R. C., Chaudhary, J. S., Thapa, B. B., Davis, D., Pokhrel, R. P., Yinghui, M., Zegans, M., Schachter, J., Frick, K. D., Tapert, L. and Lietman, T. M. (2001). Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal. Bull. World Health Organ, 79, 194-200.

Holmgren, J., Czerkinsky, C., Lycke, N. and Svennerholm, A.-M. (1992). Mucosal immunity: implications for vaccine development.  Immunobiology, 184, 157-179.

Holtmann, H., Shemer-Avni, Y., Wessel, K., Sarov, I. and Wallach, D. (1990). Inhibition of growth of Chlamydia trachomatis by tumor necrosis factor is accompanied by increased prostaglandin synthesis. Infect.Immun., 58, 3168-3172.

Igietseme, J. U., Ananaba, G. A., Bolier, J., Bowers, S., Moore, T., Belay, T., Eko, E. O., Lyn, D. and Black, C. M. (2000). Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J. Immunol, 164, 4212-4219. Full article

Igietseme, J. U., Ananaba, G. A., Bolier, J., Bowers, S., Moore, T., Belay, T., Lyn, D. and Black, C. M. (1999). The intercellular adhesion molecule type-1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice. Immunol, 98, 510-519.

Igietseme, J. U., Ananaba, G. A., Candal, D. H., Lyn, D. and Black, C. M. (1998a). Immune control of Chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction, tryptophan catabolism and iron deprivation. Microbiol. Immunol, 42, 617-625.

Igietseme, J. U., Black, C. M. and Caldwell, H. D. (2002). Chlamydia vaccines: strategies and status.  BioDrugs, 16, 19-35. [Recommended review]

Igietseme, J. U. and Murdin, A. (2000). Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect Immun, 68, 6798-6806. Full article

Igietseme, J. U., Portis, J. L. and Perry, L. L. (2001). Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun, 69, 1832-1840. Full article

Igietseme, J. U., Ramsey, K. H., Magee, D. M., Williams, D. M., Kincy, T. J. and Rank, R. G. (1993). Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunology, 5, 317-324.

Igietseme, J. U. and Rank, R. G. (1991). Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect.Immun., 59, 1346-1351.

Igietseme, J. U., Uriri, I. M., Hawkins, R. and Rank, R. G. (1996). Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia.  J.Leuk.Biol., 59, 656-662.

Igietseme, J. U., Uriri, I. M., Kumar, S. N., Ananaba, G. A., Ojior, O. O., Momodu, I. A., Candal, D. H. and Black, C. M. (1998b). Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.  Infect. Immun, 66, 4030-4035. Full article

Iwasaki, A., Stiernholm, B. J., Chan, A. K., Berinstein, N. L. and Barber, B. H. (1997). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol, 158, 4591-4601.

Jackson, J. W., Maisonneuve, J., Taylor, R. B., Tian, J., Yang, H. and Harris, A. (2001) In 101st Gen Meeting of ASM, Vol. Ab E-23 Orlando, FL, pp. 333.

Jen, S. S., Stromberg, E. J., Probst, P., Bhatia, A. and Skeiky, Y. A. W. (2001) In 101st Gen Meeting of ASM, Vol. Ab E-67 Orlando FL, pp. 343.

Jenkins, M. K., DeSilva, D. R., Johnson, J. G. and Norton, S. D. (1993) Advances in Experimental Med and Biol, 329, 87-92.

Johansson, M., Schon, K., Ward, M. and Lycke, N. (1997a) Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun, 65, 1032-1044. Full article

Johansson, M., Schon, K., Ward, M. and Lycke, N. (1997b). Front Line: Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?.  Scand J Immunol, 46, 546-552.

Johnson, R. E., Green, T. A., Schachter, J., Jones, R. B., Hook, E. W., 3rd, Black, C. M., Martin, D. H., St. Louis, M. E. and Stamm, W. E. (2000). Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J. Clin. Microbiol, 38, 4382-4386. Full article

Kalman, S., Mitchell, W., Marathe, R., Lammel, C., Fan, J., Hyman, R. W., Olinger, L., Grimwood, J., Davis, R. W. and Stephens, R. S. (1999). Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet, 21, 385-389.

Katz, B. P., Batteiger, B. E. and Jones, R. B. (1987). Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex.Transm.Dis., 14, 160-164.

Kawa, D. E. and Stephens, R. S. (2002). Antigenic topology of chlamydial PorB protein and identification of targets for immune neutralization of infectivity. J. Immunol, 168, 5184-5191. Full article

Kelly, K. A. and Rank, R. G. (1997). Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis. Infect. Immun, 65, 5198-5208. Full article

Kilmarx, P. H., Mock, P. A. and Levine, W. C. (2001). Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions. Sex. Transm Dis, 28, 347-348.

Klinman, D. M., Barnhart, K. M. and Conover, J. (1999). CpG motifs as immune adjuvants. Vaccine, 17, 19-25. Full article

Kroon, F. P., Van't Wout, J. W., Weiland, H. T. and Van Furth, R. (1989). Chlamydia trachomatis pneumonia in an HIV-seropositive patient. N.Eng.J.Med., 320, 806-807.

Kuo, C. C., Jackson, L. A., Campbell, L. A. and Grayston, J. T. (1995). Chlamydia pneumoniae (TWAR). Clin Microbiol Rev, 8, 451-461. Full review

Lagrange, P. H., Hurtrel, B. and Stach, J. L. (1985). Vaccines against mycobacteria and other intracellular multiplying bacteria. Ann Inst Pasteur Immunol, 136D, 151-162.

Lampe, M. F., Wilson, C. B., Bevan, M. J. and Starnbach, M. N. (1998). Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect. Immun, 66, 5457-5461. Full article

LaVerda, D., Kalayoglu, M. V. and Byrne, G. I. (1999). Chlamydial heat shock proteins and disease pathology: new paradigms for old problems? Infect Dis Obstet Gynecol, 7, 64-71.

Loomis, P. W. and Starnbach, M. N. (2002). T cell responses to Chlamydia trachomatis. Current Opinion in Microbiology, 5, 87-91.

Maxion, H. K. and Kelly, K. A. (2002). Chemokine expression patterns differ within anatomically distinct regions of the genital tract during Chlamydia trachomatis infection. Infect Immun, 70, 1538-1546. Full article

McClelland, R. S., Wang, C. C., Mandaliya, K., Overbaugh, J., Reiner, M. T., Panteleeff, D. D., Lavreys, L., Ndinya-Achola, J., Bwayo, J. J. and Kreiss, J. K. (2001). Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS, 15, 105-110.

McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M. and Kiyono, H. (1992). The mucosal immune system: from fundamental concepts to vaccine development. Vaccine, 10, 75-88.

Monno, R., Maggi, P., Carbonara, S., Sibilio, G., D'Aprile, A., Costa, D. and Pastore, G. (2001). Chlamydia trachomatis and Mycobacterium tuberculosis lung infection in an HIV-positive homosexual man. AIDS Patient Care STDs, 15, 607-610.

Moore, T., Ananaba, G. A., Bolier, J., Bowers, S., Belay, T., Eko, F. O. and Igietseme, J. U. (2002). Fc receptor regulation of protective immunity against Chlamydia trachomatis.  Immunol, 105, 213-221.

Moore, T., Ekworomadu, C. O., Eko, F. O., MacMillan, L., Ramey, K., Ananaba, G. A., Patrickson, J. W., Nagappan, P. R., Lyn, D., Black, C. M. & Igietseme, J. U. (2003). Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. Journal of Infectious Diseases 188, 617 - 624.

Morrison, R. P. and Caldwell, H. D. (2002). Immunity to murine chlamydial genital infection. Infect Immun, 70, 2741-2751. [Review]

Morrison, S. G. and Morrison, R. P. (2001). Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect.Immun, 69, 2643-2649. Full article

Morrison, S. G., Su, H., Caldwell, H. D. and Morrison, R. P. (2000). Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun, 68, 6979-6987. Full article

Murdin, A. D., Dunn, P., Sodoyer, R., Wang, J., Caterini, J., Brunham, R. C., Aujame, L. and Oomen, R. (2000). Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J Infect Dis, 181, S544.

Murdin, A. D., Su, H., Klein, M. H. and Caldwell, H. D. (1995). Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun, 63, 1116-1121. Full article

Neutra, M. R., Pringault, E. and Kraehenbuhl, J.-P. (1996). Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol, 14, 275-300.

O'Connell, C. M. C. and Maurelli, A. T. (Eds.) (1998) Introduction of foreign DNA into Chlamydia and stable expression of chloramphenicol resistance, Berkeley, CA, San Francisco, CA.

Ojcius, D. M., Bravo de Alba, Y., Kanellopoulos, J. M., Hawkins, R. A., Kelly, K. A., Rank, R. G. and Dautry-Varsat, A. (1998). Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J.Immunol, 160, 1297-1303. Full article

Pal, S., Barnhart, K. M., Wei, Q., Abai, A. M., Peterson, E. M. and de la Maza, L. M. (1999). Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.  Vaccine, 17, 459-465. Full article

Pal, S., Peterson, E. M. and de la Maza, L. M. (1996). Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge. Infect. Immun, 64, 5341-5348. Full article

Pal, S., Theodor, I., Peterson, E. M. and de l Maza, L. M. (1997). Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Infect. Immun, 65, 3361-3369. Full article

Perry, L. L., Feilzer, K. and Caldwell, H. D. (1997). Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J. Immunol, 158, 3344-3352.

Perry, L. L., Feilzer, K., Hughes, S. and Caldwell, H. D. (1999). Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect Immun, 67, 1379-1385. Full article

Prabhala, R. H. and Wira, C. R. (1995). Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J. Immunol, 155, 5566-5573.

Rank, R. G. (1999) In Chlamydia: intracellular biology, pathogenesis and immunity(Ed, Stephens, R. S.) ASM Press, Washington,DC, pp. 239-295.

Raulston, J. E. (1997). Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins Infect Immun, 65, 4539-4547. Full article

Richey, C. M., Macaluso, M. and Hook, E. W. (1999). Determinants of reinfection with Chlamydia trachomatis.  Sex Transm Dis, 26, 4-11.

Rockey, D. D. and Stephens, R. S. (2000). Genome sequencing and our understanding of chlamydiae.  Infect.Immun, 68, 5473-5479. Full article

Rodolakis, A., Salinas, J. and Papp, J. (1998). Recent advances on ovine chlamydial abortion. Vet Res, 29, 275-288.

Rotchford, K., Strum, A. W. and Wilkinson, D. (2000). Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: systematic review and data synthesis. Sex. Transm Dis, 27, 243-248.

Saikku, P., Wang, S. P., Kleemola, M., Brander, E., Rusanen, E. and Grayston, J. T. (1985) An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J.Infect.Dis., 151, 832-839.

Schachter, J. (1985) Overview of Chlamydia trachomatis infection and the requirements for a vaccine. Rev.Infect.Dis., 7, 713-6.

Schachter, J. (2001) NAATs to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilled. Expert Rev. Mol. Diagn, 1, 137-144.

Schachter, J. and Grayston, J. T. (1998) In Chlamydial Infections(Eds, Stephens, R. S., Byrne, G. I., Christiansen, G., Clarke, I. N., Grayston, J. T., Rank, R. G., Ridgway, G. L., Saikku, P., Schachter, J. and Stamm, W. E.) Berkeley, San Francisco, CA, pp. 3-10.

Schlesinger, S. and Dubensky, T. W. (1999) Alphavirus vectors for gene expression and vaccine. Curr Opin Biotechnol. 10, 434-439.

Singh, M. and O'Hagan, D. (1999) Advances in vaccine adjuvants. Nat Biotechnol. 17, 1075-81.

Staats, H. F., Montgomery, S. P. and Palker, T. J. (1997) Intranasal immunization is superior to vaginal, gastric, or rectal immunization for induction of systemic and mucosal anti-HIV antibody responses. AIDS Res. Hum. Retroviruses, 13, 945-952.

Stagg, A. J. (1998) Vaccines against Chlamydia: approaches and progress. Mol. Med. Today, 4, 166-173. Full article

Stagg, A. J., Tuffrey, M., Woods, C., Wunderink, E. and Knight, S. C. (1998) Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect. Immun, 66, 3535-3544. Full article

Stephens, R. S. (2000) Chlamydial Genomics and Vaccine Antigen Discovery, J Infect Dis, 181, S521-S523.

Stephens, R. S. and Lammel, C. J. (2001) Chlamydia outer membrane protein discovery using genomics. Curr Opin Microbiol, 4, 16-20.

Serlin, M., Shafer, M. A., Tebb, K., Gyamfi, A. A., Moncada, J., Schachter, J. and Wibbelsman, C. (2002) What sexually transmitted disease screening method does the adolescent prefer? Adolescents' attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination. Arch. Pediatr. Adolesc, 156, 588-591.

Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J. C. and Caldwell, H. D. (1998). Vaccination against Chlamydial Genital Tract Infection after Immunization with Dendritic Cells Pulsed Ex Vivo with Nonviable Chlamydiae. J.Exp.Med, 188, 809-818. Full article

Su, H., Messer, R., Whitmire, W., Hughes, S. and Caldwell, H. D. (2000). Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infect Immun, 68, 192-196. Full article 

Su, H., Parnell, M. and Caldwell, H. D. (1995). Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against genital tract infection. Vaccine, 13, 1023-1032.

Svanholm, C., Bandholtz, L., Castanos-Velez, E., Wigzell, H. and Rottenberg, M. E. (2000). Protective DNA immunization against Chlamydia pneumoniae. Scand J Immunol, 51, 345-353.

Thein, J., Zhao, P., Liu, H., Xu, J., Jha, H., Miao, Y., Pizzarello, L., Tapert, L., Schachter, J., Mabon, M., Osaki-Holm, S., Lietman, T. and Paxton, A. (2002) Does clinical diagnosis indicate chlamydial infection in areas with a low prevalence of trachoma? Ophthalmic Epidemiol, 9, 263-269.

Thior, I., Diouf, G., Diaw, I. K., Sarr, A. D., Hsieh, C. C., Ndoye, I., Mboup, S., Chen, L., Essex, M., Marlink, R. and Kanki, P. (1997) Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal.  Afr. J. Reprod. Health, 1, 26-35.

Turner, M. S. and Giffard, P. M. (1999) Expression of Chlamydia psittaci- and human immunodeficiency virus-derived antigens on the cell surface of Lactobacillus fermentum BR11 as fusion to bspA. Infect Immun, 67, 5486-5489. Full article

Wang, S., Fan, Y., Brunham, R. C. and Yang, X. (1999).  IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection. Eur J Immunol, 29, 3782-3792.

Wang, S. and Grayston, J. T. (1991). Three new serovars of Chlamydia trachomatis: Da, Ia, and L₂a. J. Infect.Dis., 163, 403-405.

Wilkinson, D. and Rutherford, G. (2001) Population-based interventions for reducing sexually transmitted infections, including HIV infection, Cochrane Databse Syst Rev, (2), CD001220.

Woolridge, R. L., Grayston, J. T., Chang, I. H., Yang, C. Y. and Cheng, K. H. (1967). Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am. J. Ophthalmol, 63, 1650-1655.

Wu, H.-Y., Nikolova, E. B., Beagley, K. W. and Russell, M. W. (1996). Induction of antibody-secreting cells and T helper  and memory cells in murine nasal lymphoid tissue. Immunol., 88, 493-500.

Wu, H.-Y. and Russell, M. W. (1997). Nasal Lymphoid Tissue, Intranasal Immunization, and Compartmentalization of the Common Mucosal Immune System.  Immunol.Res, 16, 187-201.

Wylie, J. L., Wang, L. L., Tipples, G. and McClarty, G. (1996). A single point mutation in CTP synthetase of Chlamydia trachomatis confers resistance to cyclopentenyl cytosine. J Biol Chem, 271, 15393-15400. Full article

Yang, X. and Brunham, R. C. (1998) Role of  T cell-mediated immunity in host defense against Chlamydia trachomatis and its implication for vaccine development, Can J Infect Dis, 9, 99.

Yang, X., Gartner, J., Zhu, L., Wang, S. and Brunham, R. C. (1999).  IL-10 Gene Knockout Mice Show Enhanced Th1-Like Protective Immunity and Absent Granuloma Formation Following Chlamydia trachomatis Lung Infection. J. Immunol, 162, 1010-1017. Full article

Yang, X., HayGlass, K. T. and Brunham, R. C. (1996). Genetically determined differences in IL-10 and IFN-g responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J.Immunol, 156, 4338-4344.

Zhong, G. and de la Maza, L. M. (1988) Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1.  Infect.Immun., 56, 3322-3325.

Zhong, G., Liu, L., Fan, T., Fan, P. and Ji, H. (2000). Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells. J.Exp.Med, 191, 1525-1534. Full article

NEXT: Biology index